Push for growth in emerging markets like Brazil, Russia, India and China (BRIC).
For some Med-Tech Companies, growth rates in emerging markets are double, triple and in some cases 10-fold those in the US and other developed markets. This trend was clearly evident as I listened to and reviewed transcripts from Q4 2012 earnings calls from Johnson & Johnson, Boston Scientific, and Medtronic.
While emerging markets continue to present significant growth opportunities, how can med-tech companies address the variety of needs and delivery models in these markets, while addressing increasing pricing pressures in developed economies?
To learn key strategies Med-Tech Executives are utilizing to push for growth in BRICs, click on this link to read the complete article.
This is an excerpt from our recently published article in MedicalDeviceSummit.